These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37015283)

  • 21. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
    Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Matsumura Y; Nagao M; Yamamoto M; Tsuchido Y; Noguchi T; Shinohara K; Yukawa S; Inoue H; Ikeda T
    Emerg Infect Dis; 2022 Aug; 28(8):1569-77. PubMed ID: 35710464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021.
    Shobayo B; Mishra M; Sameroff S; Petrosov A; Ng J; Gokden A; MaCauley J; Jain K; Renken C; Duworko JT; Badio M; Jallah W; Hensley L; Briese T; Lipkin WI; Mishra N
    Emerg Infect Dis; 2021 Dec; 27(12):3185-3188. PubMed ID: 34708683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam.
    Hoang TH; Vu GM; Tran MH; Tran TTH; Le QD; Tran KV; Nguyen TT; Nguyen LTN; Tran TH; Ta VT; Vo NS
    BMC Infect Dis; 2022 Jun; 22(1):558. PubMed ID: 35718768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
    Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital outbreak of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant in partially and fully vaccinated patients and healthcare workers in Toronto, Canada.
    Susky EK; Hota S; Armstrong IE; Mazzulli T; Kestenberg S; Casaubon LK; Granton J; Rebelo C; Bartels E; Wrana J; Vaisman A
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):328-331. PubMed ID: 34706787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of SARS-CoV-2 Delta Variant, Benin, May-July 2021.
    Yadouleton A; Sander AL; Adewumi P; de Oliveira Filho EF; Tchibozo C; Hounkanrin G; René KK; Ange D; Kohoun RK; Nari RC; Salifou S; Saizonou R; Kakai CG; Bedié SV; Al Onifade F; Nagel M; Aïssi MAJ; Akogbeto P; Drosten C; Wulf B; Moreira-Soto A; Djingarey MH; Hounkpatin B; Drexler JF
    Emerg Infect Dis; 2022 Jan; 28(1):205-209. PubMed ID: 34807815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
    Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
    Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
    Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K
    J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectiveness.
    Smoll N; Walker J; Hassan Al Imam M; Auriac J; Andrews R; Jeremijenko A; Kirk M; Khandaker G
    Commun Dis Intell (2018); 2022 Aug; 46():. PubMed ID: 35981815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.
    Laiton-Donato K; Villabona-Arenas CJ; Usme-Ciro JA; Franco-Muñoz C; Álvarez-Díaz DA; Villabona-Arenas LS; Echeverría-Londoño S; Cucunubá ZM; Franco-Sierra ND; Flórez AC; Ferro C; Ajami NJ; Walteros DM; Prieto F; Durán CA; Ospina-Martínez ML; Mercado-Reyes M
    Emerg Infect Dis; 2020 Dec; 26(12):2854-2862. PubMed ID: 33219646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020-2022.
    Puenpa J; Rattanakomol P; Saengdao N; Chansaenroj J; Yorsaeng R; Suwannakarn K; Thanasitthichai S; Vongpunsawad S; Poovorawan Y
    Arch Virol; 2023 Jan; 168(1):26. PubMed ID: 36593392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021.
    Yaglom HD; Maurer M; Collins B; Hojnacki J; Monroy-Nieto J; Bowers JR; Packard S; Erickson DE; Barrand ZA; Simmons KM; Brock BN; Lim ES; Smith S; Hepp CM; Engelthaler DM
    PLoS One; 2022; 17(10):e0272830. PubMed ID: 36315517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.